Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2002 Sep 4;87(6):689. doi: 10.1038/sj.bjc.6600504

Heparanase is a prognostic indicator for postoperative survival in pancreatic carcinoma

J Rohloff, J Zinke, K Schoppmeyer, A Tannapfel, H Witzigmann, J Mössner, C Wittekind, K Caca
PMCID: PMC2364236

Abstract

British Journal of Cancer (2002) 87, 689–689. doi:10.1038/sj.bjc.6600504 www.bjcancer.com

© 2002 Cancer Research UK

Correction to: British Journal of Cancer (2002) 86, 1270. doi:10.1038/sj/bjc/6600232

The authors would like to thank InSight Ltd., Rehovot, Israel for providing them with the anti-heparanase antibody and heparanase cDNA used in the study.

The mentioned reagents are proprietary of InSight.


Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES